Anemia in Hypothyroidism: Why It Happens and Which Type

Anemia is present in 20–60% of hypothyroid patients and comes in three main types: normocytic (anemia of chronic disease from low thyroid hormone), microcytic (iron deficiency), and macrocytic (B12 or folate deficiency, including pernicious anemia from autoimmune overlap with Hashimoto's). Treating thyroid alone is often not enough — check ferritin, B12, MCV, and rule out pernicious anemia.

Why hypothyroidism causes anemia

Thyroid hormone is a direct driver of bone marrow erythropoiesis — it stimulates the kidneys to produce erythropoietin and supports the proliferation and maturation of red cell precursors [C1]. When thyroid hormone is low, the marrow output of red cells slows, oxygen consumption falls, and the body recalibrates around a lower red cell mass. The result is a mild-to-moderate anemia that mirrors the depth and duration of the hypothyroid state [C1][C2].

But the anemia of hypothyroidism is not one disease — it is at least three overlapping mechanisms, and the type often reveals what is actually happening underneath:

• Normocytic anemia (normal MCV). The "pure" anemia of hypothyroidism — a chronic-disease-pattern picture driven by reduced erythropoietin and direct marrow suppression. It improves as TSH normalizes on levothyroxine [C1][C2].
• Microcytic anemia (low MCV). Iron deficiency. Low thyroid hormone reduces gastric acid output, which lowers iron absorption; menorrhagia is also common in untreated hypothyroidism and depletes iron stores [C1][C5]. Iron deficiency is a feedback loop — low iron also reduces the activity of thyroid peroxidase, the enzyme that builds thyroid hormone [C5].
• Macrocytic anemia (high MCV). Vitamin B12 deficiency, folate deficiency, or both. In Hashimoto's specifically, this is often pernicious anemia — an autoimmune attack on the parietal cells and intrinsic factor in the stomach that disables B12 absorption [C3][C4].

Reported prevalence varies but anemia of some type is found in roughly 20–60% of hypothyroid patients across studies, with iron deficiency the most common subtype [C1][C2].

The clinical pattern

The overlap between hypothyroid symptoms and anemia symptoms is almost complete: fatigue, cold intolerance, breathlessness on exertion, pallor, hair shedding, brain fog. This is why anemia in hypothyroidism is so often missed — both diagnoses produce the same complaint, and the patient (and sometimes the clinician) attributes everything to the thyroid [C1][C2].

Two clinical signals should raise suspicion for a coexisting anemia:

• Symptoms that don't track TSH. Fatigue and breathlessness that persist after TSH normalizes [C1][C6].
• An abnormal MCV. A low MCV points to iron deficiency. A high MCV points to B12 or folate deficiency — and in a Hashimoto's patient, that finding should trigger a workup for pernicious anemia [C3][C4].

In Hashimoto's specifically, the overlap with autoimmune gastritis is well-documented. The Cellini 2017 series and related reviews report autoimmune gastritis or its serologic markers (anti-parietal cell antibodies, anti-intrinsic factor antibodies) in a substantial subset of Hashimoto's patients — earlier estimates suggested roughly 3–12% develop frank pernicious anemia [C3][C4]. The shared autoimmune background (both conditions cluster in autoimmune polyglandular syndrome type 3) explains the overlap [C3].

What recovers on adequate levothyroxine

The normocytic anemia of hypothyroidism is usually thyroid-responsive [C1][C2]:

• Weeks 4–12: Hemoglobin starts to rise as marrow output increases with normalized thyroid hormone signaling.
• Months 3–6: Most patients with pure thyroid-driven anemia reach a stable, normal hemoglobin once TSH is in target range (often 0.5–2.5 mIU/L symptomatic target) [C6].
• Iron- or B12-driven anemia: Does not fully resolve on levothyroxine alone — the nutritional deficit must be treated in parallel [C1][C5][C8].

This is the central practical message: levothyroxine fixes the thyroid contribution to anemia, but it cannot replace iron or B12 the patient does not have.

When fatigue persists despite normal TSH

If a patient remains fatigued, short of breath, or pale after TSH normalizes, anemia is one of the highest-yield differentials [C1][C2]. The relevant scenarios:

1. Untreated iron deficiency. Common in menstruating women; ferritin under 30 ng/mL is a reasonable threshold to act on, even with hemoglobin still in the normal range. See our iron-deficiency-thyroid article.
2. Untreated B12 deficiency. B12 deficiency is meaningfully more common in primary hypothyroidism than in the general population — older series report rates around 40% [C8], and a 2023 systematic review and meta-analysis confirms lower mean B12 levels in autoimmune thyroid disease [C4]. See our vitamin-b12-hypothyroidism article.
3. Undiagnosed pernicious anemia. In any Hashimoto's patient with a high MCV, low B12, or unexplained fatigue, the workup should include anti-intrinsic-factor antibodies and (if available) anti-parietal-cell antibodies; gastroenterology can confirm with endoscopy and biopsy [C3][C4].
4. Concurrent celiac disease. Celiac is also over-represented in autoimmune thyroid disease and is a common cause of iron and B12 malabsorption — worth screening if anemia is recurrent or refractory.
5. Over-replacement. Suppressed TSH (below 0.1 mIU/L) does not fix anemia and adds its own fatigue, palpitations, and bone loss risk. Confirm the dose is right [C6].

What does NOT help

Several common moves do not address the actual mechanism:

• Adding more levothyroxine "to push through" persistent fatigue. If the anemia is iron- or B12-driven, more thyroid hormone will not fix the red cell mass — and over-replacement adds its own harms [C6].
• Routine oral B12 in pernicious anemia. Standard oral B12 absorption depends on intrinsic factor, which is the molecule pernicious anemia destroys. Patients with confirmed pernicious anemia typically need parenteral B12 (intramuscular injection) or high-dose oral B12 under medical supervision [C3][C4].
• "Thyroid hair / energy / metabolism" multivitamins. Most contain iodine, biotin, ashwagandha, and kelp. Biotin interferes with thyroid lab measurement, iodine can destabilize Hashimoto's, and none of these address anemia [C6].
• Iron supplementation taken simultaneously with levothyroxine. Iron binds levothyroxine in the gut and reduces absorption. Separate the doses by at least 4 hours [C6].

Practical guidelines

1. Check a CBC with MCV at the time of TSH testing — the MCV is the most informative single number for typing the anemia [C1][C2].
2. Order ferritin, vitamin B12, and folate in any hypothyroid patient with anemia, ongoing fatigue, or restless legs [C1][C5][C8]. Ferritin under 30 ng/mL warrants iron repletion; B12 under ~300 pg/mL warrants follow-up testing.
3. If MCV is high or B12 is low in a Hashimoto's patient, screen for pernicious anemia with anti-intrinsic-factor antibodies (and anti-parietal-cell antibodies where available) [C3][C4]. Gastroenterology referral if positive.
4. Treat the deficiency, not just the thyroid. Iron repletion for microcytic anemia; B12 (parenteral if pernicious anemia is confirmed) for macrocytic anemia; levothyroxine for the normocytic component [C1][C6].
5. Separate iron and levothyroxine by ≥4 hours to protect absorption [C6].
6. Recheck CBC and the deficient micronutrient at 8–12 weeks to confirm response [C6].

Frequently asked questions

My TSH is normal but I'm still exhausted — could it be anemia? Yes, and it's one of the most common reversible causes of persistent fatigue in treated hypothyroidism. Ask for a CBC with MCV, ferritin, and vitamin B12. The MCV tells you which type of anemia to look for [C1][C2].

What is pernicious anemia and how is it related to Hashimoto's? Pernicious anemia is an autoimmune disease that destroys the stomach cells that absorb vitamin B12. It clusters with Hashimoto's because they share an autoimmune background, with earlier estimates suggesting roughly 3–12% of Hashimoto's patients develop it [C3][C4]. The diagnosis is made by combining low B12, a high MCV, and positive anti-intrinsic-factor antibodies [C3].

Can I just take a B12 supplement instead of getting tested? You can, but if you have pernicious anemia, oral B12 absorbed through the normal route requires intrinsic factor — which pernicious anemia destroys. You may need parenteral (intramuscular) B12 or high-dose oral B12 under medical supervision. Testing first is the right path [C3][C4].

Should I take iron with my levothyroxine? No. Iron binds levothyroxine in the gut and reduces absorption — separate doses by at least 4 hours [C6]. Most people take levothyroxine in the morning fasted and iron later in the day with food.

How long does the anemia of hypothyroidism take to fix? The thyroid-driven component (normocytic) usually improves within 3 to 6 months of stable TSH. Iron deficiency takes 3 to 6 months of repletion to refill stores. B12 deficiency starts to respond in weeks but full neurologic recovery can take months [C1][C2][C6].

Bottom line

Anemia is common in hypothyroidism — across studies, roughly 20–60% of patients have anemia of some type [C1][C2]. The MCV separates them: normocytic (thyroid-driven, resolves on levothyroxine), microcytic (iron deficiency), or macrocytic (B12 or folate deficiency, often pernicious anemia in Hashimoto's patients) [C1][C3][C4]. Treating thyroid alone leaves the iron and B12 deficiencies in place, which is the single most common reason fatigue persists despite a normal TSH [C1][C8]. The right workup — CBC with MCV, ferritin, B12, plus pernicious anemia antibodies in Hashimoto's patients with a high MCV — separates the patients who only need a dose adjustment from the ones who need repletion or parenteral B12 [C3][C4][C6].

Sources

1. [C1] Szczepanek-Parulska E, Hernik A, Ruchała M. Anemia in thyroid diseases. Pol Arch Intern Med. 2017;127(5):352–360. PubMed: 28400547
2. [C2] Erdogan M et al. Characteristics of anemia in subclinical and overt hypothyroid patients. Endocr J. 2012;59(3):213–220. PubMed: 22200582
3. [C3] Cellini M et al. Hashimoto's Thyroiditis and Autoimmune Gastritis. Front Endocrinol. 2017;8:92. PubMed: 28491051
4. [C4] Benites-Zapata VA et al. Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis. 2023. PubMed: 36909313
5. [C5] Garofalo V et al. Relationship between Iron Deficiency and Thyroid Function: A Systematic Review and Meta-Analysis. 2023. PubMed: 38004184
6. [C6] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
7. [C7] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org
8. [C8] Jabbar A et al. Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc. 2008;58(5):258–261. PubMed: 18655403

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.